Replay available

ImmuCell Corporation (ICCC) Q1 2026 Earnings Call

ImmuCell Corporation (NASDAQ: ICCC) Q1 2026 earnings conference call, held 2026-05-15. Replay captured from the company's public earnings webcast.

Fri, May 15, 2026 at 9:00 AMendedReplay
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Timothy Fiore

Chief Financial Officer

Oliver Taboukar

President and CEO

George Milos

Analyst, MKH Management

Frank Gasker

Private Investor

Joe Diaz

Investor Relations, Lithium Partners

Replay transcript excerpt

Good morning and welcome to the MU Cell Corporation conference call to discuss unaudited first quarter 2026 financial results. Today, all participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event today is being recorded. I would now like to turn the conference call over to Joe Diaz of Litham Partners. Please proceed. Thank you, Chris. Good morning and welcome. As the operator indicated, my name is Joe Diaz with Lithium Partners. We are the investor relations consulting firm for Emucell. I thank you for joining us today to discuss the unaudited earnings for the first quarter ended March 31, 2026. Listeners are reminded and cautioned that statements made by management during the course of this call include forward-looking statements, which include any statement that refers to future events or expected future results or predictions about the steps the company plans to take in the future. These statements are not guarantees of performance and are subject to risks and uncertainty that could cause actual results, outcomes, or events to differ materially from those discussed today. Additional information regarding forward-looking statements and the risks and uncertainty that could impact future results, outcomes, or advances available under the cautionary note regarding forward-looking statements, or better known as the safe harbor statement, provided with the press release that the company filed last night, along with the company's other periodic filings with the SEC. Information discussed on today's call speaks only as of today, Friday, May 15, 2026. The company undertakes no obligation to update any information discussed on today's call. Please note that references to certain non-GAAP finan...

More from Immucell Corporation